Clinical trials
Phase 2 Lymphoma, Follicular trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Regeneron Pharmaceuticals | 2 |
| AstraZeneca | 1 |
| Celgene | 1 |
| Eisai Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
| Incyte Biosciences Japan GK | 1 |
| Merck Sharp & Dohme LLC | 1 |
| SymBio Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 12 |
| Lymphoma, B-Cell | 5 |
| Lymphoma, Non-Hodgkin | 4 |
| Recurrence | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Lymphoma | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.